Variables | HR | OR | ||||
---|---|---|---|---|---|---|
Tau² | t-value | P-value | Tau² | t-value | P-value | |
Sample size | 0.0753 | -0.3248 | 0.0007 | 0.0931 | -0.1552 | 0.0449 |
>=1000 | Â | Â | Â | Â | Â | Â |
<1000 | Â | Â | Â | Â | Â | Â |
Age | 0.0552 | - | 0.1123 | 0.0746 | - | 0.3495 |
>=60 | Â | 0.1404 | 0.1206 | Â | 0.1006 | 0.1674 |
<60 | Â | Â | Â | Â | Â | Â |
NR | Â | 0.7562 | 0.1143 | Â | 0.1713 | 0.5027 |
Male (%) | 0.0734 | 0.0351 | 0.7253 | 0.0997 | - | 0.0086 |
>=50 | Â | Â | Â | Â | -0.0678 | 0.4355 |
<50 | Â | Â | Â | Â | Â | Â |
NR | Â | Â | Â | Â | 0.4272 | 0.0119 |
Study design | 0.0774 | - | 0.0828 | 0.0796 | - | 0.8863 |
Retrospective/case series | Â | 0.1064 | 0.3152 | Â | -0.0034 | 0.9647 |
Prospective study | Â | 0.1064 | 0.1628 | Â | -0.0823 | 0.6301 |
Others | Â | Â | Â | Â | Â | Â |
Region | 0.0651 | - | 0.1800 | 0.0601 | - | <0.0001 |
Europe | Â | -0.1169 | 0.2910 | Â | -0.0307 | 0.7439 |
North America | Â | -0.2287 | 0.0746 | Â | -0.2362 | 0.0132 |
Asia | Â | Â | Â | Â | Â | Â |
Others | Â | 0.3260 | 0.3447 | Â | 1.3471 | <0.0001 |
Disease | 0.0702 | - | 0.8655 | 0.1005 | - | 0.4005 |
CVD | Â | -0.1123 | 0.4286 | Â | 0.1737 | 0.1365 |
Cardiac disease | Â | -0.0681 | 0.6418 | Â | 0.1620 | 0.1741 |
HF | Â | -0.1221 | 0.5212 | Â | 0.2230 | 0.0640 |
CAD | Â | Â | Â | Â | Â | Â |
Others | Â | Â | Â | Â | 0.82 | 0.413 |
Outcomes | 0.0694 | - | 0.0375 | 0.0810 | - | 0.1400 |
Mortality | Â | -0.0990 | 0.6880 | Â | -0.1298 | 0.2733 |
Severity | Â | -0.4713 | 0.0915 | Â | -0.2786 | 0.0528 |
Disease progression | Â | Â | Â | Â | Â | Â |